ArticleViruses2026

Development and Validation of a Rapid Titer Assay for the Oncolytic Virus oHSV2 Expressing a PD-L1/CD3 Bispecific Antibody.

Shengjie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.